Evidence map›Paper›PMID 35800144›Full record

ArticleSaudi journal of biological sciences2022

Therapeutic effect of antihypertensive drug on diabetic nephropathy: Functional and structural kidney investigation.

Seyedeh Masoumeh Ghoreishi, Mehrangiz Amiri, Ali Shabestani Monfared, Faezeh Hamidi, Hossein Najafzadehvarzi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi journal of biological sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Seyedeh Masoumeh GhoreishiCellular and Molecular Research Center, Babol University of Medical Sciences, Babol, Iran.
Mehrangiz AmiriDepartment of Nuclear Medicine, Babol University of Medical Sciences, Babol, Iran.
Ali Shabestani MonfaredCancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Faezeh HamidiIslamic Azad University, Ayatollah Amoli Branch, Amol, Mazandaran, Iran.
Hossein NajafzadehvarziCellular and Molecular Research Center, Babol University of Medical Sciences, Babol, Iran.
Babol University of Medical Sciences · IRIslamic Azad University of Ayatollah Amoli · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the growth of diabetic mellitus (DM) and diabetic nephropathy as a significant complication for diabetic patients, study on effective treatment with fewer side effects has been fascinated. In this study for the first time carvedilol effects on both function and structure of kidney in diabetic nephropathy treatment were evaluated. Diabetes was induced by injection of streptozotocin (STZ) intravenously in rats and three groups including control, diabetic, and treatment with carvedilol were considered. Biochemical parameters such as, blood glucose level, BUN, creatinine, uric acid, Na

Indexed as

Biochemical factorsCarvedilolDiabetesSPECT imaging

Identifiers

PMID35800144
PMCPMC9253481
OpenAlexW4283160960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.